| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 05/17/2001 | WO2001034187A2 Preparation and method for prevention of coccidiosis |
| 05/17/2001 | WO2001034159A1 Protease inhibitors |
| 05/17/2001 | WO2001034158A1 Protease inhibitors |
| 05/17/2001 | WO2001034157A1 Protease inhibitors |
| 05/17/2001 | WO2001034149A1 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| 05/17/2001 | WO2001033966A2 Active ingredient combination having insecticidal and acaricidal characteristics |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | WO2000076457A3 Il-8 receptor antagonists |
| 05/17/2001 | DE19954394A1 Verwendung von Polysiloxanen mit quartären Aminogruppen als Formulierungshilfe und Mittel enthalten dieselben Use of polysiloxanes with quaternary amino groups as a formulation aid and medium containing the same |
| 05/17/2001 | CA2404763A1 Mutated il-13 molecules and their uses |
| 05/17/2001 | CA2390421A1 24 human secreted proteins |
| 05/17/2001 | CA2388643A1 Use of lytic toxins and toxin conjugates |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/17/2001 | CA2387959A1 21 human secreted proteins |
| 05/16/2001 | EP1084709A9 Oral recombinant lactobacilli vaccines |
| 05/16/2001 | EP0753009B1 Malaria peptides |
| 05/16/2001 | CN1295126A Specific DNA sequence of oriental vole and its use |
| 05/16/2001 | CN1294911A Substituted nitrobenzene derivative for medicine and other use |
| 05/15/2001 | US6232328 Non-systemic control of parasites |
| 05/15/2001 | US6232305 Substituted amino bicyclic-β-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 05/15/2001 | US6232290 Cyclic hexapeptides with antimicrobial activity |
| 05/15/2001 | US6231878 Spraying acid water and electrolysis, oxidation-reduction potentials for skins |
| 05/10/2001 | WO2001032687A1 10 human secreted proteins |
| 05/10/2001 | WO2001032631A2 Heterocyclic cytotoxic agents |
| 05/10/2001 | WO2001032629A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 05/10/2001 | WO2001032216A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 05/10/2001 | WO2001032208A1 Adjuvanted genetic vaccines |
| 05/10/2001 | WO2001032156A2 Methods for treating fibroproliferative diseases |
| 05/10/2001 | WO2001032144A1 Dry powder compositions having improved dispersivity |
| 05/10/2001 | WO2000063241A3 Methods and compositions for modulating an immune response |
| 05/10/2001 | DE19953775A1 Wirkstoffkombinationen mit insektiziden und akariziden Eigenschaften Drug combinations with insecticidal and acaricidal properties |
| 05/10/2001 | CA2389686A1 Adjuvanted genetic vaccines |
| 05/10/2001 | CA2389661A1 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 05/10/2001 | CA2389312A1 Heterocyclic cytotoxic agents |
| 05/10/2001 | CA2387754A1 10 human secreted proteins |
| 05/09/2001 | EP1097154A1 Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas |
| 05/09/2001 | EP0514411B1 Polypeptides and dna encoding same, associated with human malaria parasites |
| 05/08/2001 | US6228890 Use of alicyclic diamines as immunomodulators |
| 05/08/2001 | US6228847 Inhibitors of nucleoside metabolism |
| 05/08/2001 | US6228649 Double targeted gene replacement in unicellular diploid organisms |
| 05/08/2001 | US6228601 Polypeptides for diagnosing infection with trypanosoma cruzi |
| 05/08/2001 | US6228372 Polypeptides with amino acid sequences and peptides |
| 05/08/2001 | CA2011896C Ringworm vaccine |
| 05/03/2001 | WO2001031003A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | WO2001030848A2 Nucleic acids of the human abc1 gene and applications thereof |
| 05/03/2001 | WO2001030795A1 Hygromycin derivatives |
| 05/03/2001 | WO2001030793A1 Hygromycin a prodrugs |
| 05/03/2001 | WO2001030776A1 Novel limonoids for use particularly in the treatment of cancer and method for producing the same |
| 05/03/2001 | WO2001030774A1 Substituted indoles for modulating nfkb activity |
| 05/03/2001 | WO2001030772A1 Compounds and their use as cysteine protease inhibitors |
| 05/03/2001 | WO2001030448A1 Method and compositions for administering taxanes orally to human patients |
| 05/03/2001 | WO2001030365A1 Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis |
| 05/03/2001 | WO2000066107A3 Antimalarian agents for the treatment of asthma |
| 05/03/2001 | WO2000063245A3 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 05/03/2001 | DE19951360A1 Substituierte Indole Substituted indoles |
| 05/03/2001 | CA2389583A1 Method and compositions for administering taxanes orally to human patients |
| 05/03/2001 | CA2389522A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | CA2389191A1 Hygromycin derivatives |
| 05/03/2001 | CA2389169A1 Novel limonoids for use particularly in the treatment of cancer and method for producing the same |
| 05/03/2001 | CA2389019A1 Hygromycin a prodrugs |
| 05/03/2001 | CA2388950A1 Nucleic acids of the human abc1 gene and their therapeutic and diagnostic application |
| 05/02/2001 | EP1095662A1 New vaccine composition and use of surfactants as immuno-adjuvant |
| 05/02/2001 | EP1095050A1 Phosphorous organic compounds and their use |
| 05/02/2001 | EP1095042A1 Antiparasitic artemisinin derivatives (endoperoxides) |
| 05/02/2001 | CN1293664A Cyclooctadepsipeptides and their use for combating endoparasites |
| 05/02/2001 | CN1293568A Lipophilic microparticles containing protein drug or antigen and formulation comprising same |
| 05/02/2001 | CN1293012A Aloe-meat sausage |
| 05/02/2001 | CN1065277C Process for preparation of avermectins |
| 05/01/2001 | CA2203464C Antimycotic ectoparasiticidal product - external use |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029042A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001028537A2 Bissulfonamide derivatives as enzyme inhibitors |
| 04/26/2001 | WO2000058328A3 Avermectin derivatives |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | US20010000521 Biological activity inhibiting topoisomerase I and/or topoisomerase II; antitumor agents, viricides |
| 04/26/2001 | CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | CA2387593A1 Enzyme inhibitors |
| 04/25/2001 | EP1093465A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 04/24/2001 | US6222014 Amino acid sequence of protein from ribonucleotide diphosphate reductase family; drug screening of bactericides and antibiotics |
| 04/24/2001 | US6221894 Nodulisporic acid derivatives |
| 04/24/2001 | US6221877 In particular bovine trichomoniasis and giardiasis |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | US6221366 Intestinal protozoal vaccines |
| 04/24/2001 | CA2032233C Pour-on formulations effective for the control of internal and external parasites of homothermic animals |
| 04/19/2001 | WO2001027314A1 Antiprotozoal histone acetyl transferase inhibitors |
| 04/19/2001 | WO2001026682A2 Modified plant viruses and methods of use thereof |
| 04/19/2001 | WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/19/2001 | WO2001026627A1 Liposome encapsulated silver salt compositions |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2000070086A9 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
| 04/19/2001 | CA2387629A1 Modified plant viruses and methods of use thereof |
| 04/19/2001 | CA2387145A1 Liposome encapsulated silver salt compositions |
| 04/19/2001 | CA2386299A1 Antiprotozoal histone acetyl transferase inhibitors |
| 04/18/2001 | EP1092437A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 04/18/2001 | EP1091740A1 Semi-solid aqueous preparations for oral applications of toltrazuril sulphone |
| 04/18/2001 | EP0935462A4 Photopheresis treatment of leukocytes |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |